DOI 10.1016/j.jconrel.2026.115037
A bifunctional molecular adaptor drives immune cell-hitchhiked delivery of protein therapeutics.
Аннотация
Protein therapeutics hold transformative potential for disease treatment, yet their clinical efficacy remains constrained by formidable physiological and pathological barriers. Here, we present a bifunctional molecular adaptor that enables immune cell-hitchhiked transport of protein drugs. This adaptor functionalizes proteins through controllable conjugation, while simultaneously promoting their rapid entry into circulating immune cells following systemic administration. The protein-bifunctional molecule conjugates not only retain bioactivity but also exploit immune cells as endogenous carriers to achieve inflammation-targeted delivery. We delineate the structure-activity relationships governing adaptor design, revealing its high targeting efficiency and a non-endocytic internalization mechanism. In murine models of lipopolysaccharide-induced sepsis, protein-bifunctional molecule conjugates efficiently targeted inflamed organs, alleviated sepsis-induced tissue and organ damage, and improved survival in septic shock. These findings establish a bifunctional molecular adaptor as a clinically translatable strategy to overcome longstanding barriers in the targeted delivery of protein therapeutics.
Предметные рубрики MeSH
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.